Meiragtx: See Their Revenue, Competitors, Traffic, and Reviews (August 2025)

Review (August 2025)

15M

Estimated Revenue

10k

Website Visitors

4/5

Trustpilot Score

What do we know about MeiraGTx?

Estimated Revenue (2020)

$15M

Total Employees

190 Founded

2015

Industry

Biotechnology

Location

London, United Kingdom

About

MeiraGTx:

Social Links

What is MeiraGTx's Revenue?

MeiraGTx's estimated revenue for 2024 is $15M.

What does MeiraGTx do?

MeiraGTx is a clinical-stage gene therapy company focused on developing potentially curative treatments for patients living with serious diseases. We currently have six programs in clinical development including four ocular indications, a salivary gland condition, and a Parkinson's disease program. Our initial focus on diseases of the eye, salivary gland and central nervous system is based on the significant unmet medical need coupled with the high potential gene therapy has to provide meaningful clinical benefit in these areas. With headquarters in New York and London, our global footprint provides us the opportunity to partner with leading institutions around the world, allowing us to deepen our understanding of diseases and their progression. Our team was built with deep expertise in gene therapy development, allowing us to efficiently advance our programs from preclinical to clinical development. Our core capabilities in viral vector design and optimization and gene therapy manufacturing give us a differentiated approach to developing gene therapies. Additionally, we are developing proprietary technology to potentially enable innovative gene therapy treatments whose expression can be turned on and off with an easily administered small molecule. We believe temporal control of gene therapy products has the potential to transform the gene therapy landscape. Our state-of-the-art manufacturing facility, completed in early 2018, was designed to meet global regulatory requirements, including the current good manufacturing practices (cGMP) required by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK and the U.S. Food and Drug Administration (FDA). The 29,000-square foot facility has the flexibility and capacity to produce sufficient product for all our clinical trials and will scale to commercial capacity.

Ruggable

Shop area rugs, accent rugs and runner rugs at ruggable. washable, stain-resistant and waterproof, our rugs are perfect for homes with kids and pets. ships free!... More